EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Amorphous solid dispersions of amphiphilic polymer excipients and indomethacin prepared by hot melt extrusion

Larissa Keßler, Rashmi Mishra, Sami Hietala, Manon Lammens, Leena Peltonen, Thomas Rades, Bert van Veen, Anne Juppo, Timo Laaksonen, Clare Strachan, Robert Luxenhofer

European Journal of Pharmaceutical Sciences · 2025

DOI: 10.1016/j.ejps.2024.106960 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutical Sciences, 2025. Verfasst von Larissa Keßler und 10 weiteren Autor:innen. Beteiligte Einrichtung: Soft Matter Chemistry, Department of Chemistry, and Helsinki Institute of Sustainability Science, Faculty of Science, University of Helsinki, Helsink…. Hauptthemen laut MEDLINE: Indomethacin, Excipients, Polymers, Solubility. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Finland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Improving the solubility of poorly water-soluble drugs is essential for enhancing bioavailability, formulation flexibility and reducing patient-to-patient variability. The preparation of amorphous solid dispersions (ASDs) is an attractive strategy to formulate such drugs, leading to higher apparent water solubility and therefore higher bioavailability. For such ASDs, water-soluble polymer excipients, such as poly(vinyl pyrrolidone) (PVP) or poly(vinyl pyrrolidone-co-vinyl acetate) (P(VP-co-VA)), are employed to solubilize and stabilize the drug against crystallization. We posit that polymers bearing tertiary amides are particularly well suited to stabilizing drugs containing H-bond donors, as they offer strong H-bonding potential between the polymer and drug. The aim of this study was to compare new and established polymers with tertiary amides as excipients for ASDs. Experimental amphiphilic ABA triblock copolymers comprising poly(2-methyl-2-oxazoline) (pMeOx), poly(2‑butyl‑2-oxazoline) (pBuOx) and poly(2‑butyl‑2-oxazine) (pBuOzi) blocks, were compared with the established excipients, PVP and P(VP-co-VA). ASDs with indomethacin as the model drug were prepared at high drug loadings via hot melt extrusion. The extrudates were studied with DSC and PXRD, revealing the ASDs to be fully amorphous up to 75wt% indomethacin, independent of the polymer used. 13C CPMAS NMR provided insights into intermolecular associations as a function of drug loading, and suggested the presence of drug dimers at 75wt% drug loading in pMeOx-pBuOzi-pMeOx and pMeOx-pBuOx-pMeOx, which could affect physical stability. Independent of the polymers, the solid-state form of the drug in the ASD was found to affect the dissolution profile of the samples, insofar as the samples containing crystalline indomethacin showed slower dissolution than the fully amorphous ones. This study shows that the polymers comprising poly(2-oxazoline) and poly(2-oxazine) are effective polymers for ASD preparation, similar to PVP and P(VP-co-VA) which merits further investigations into these novel polymers for formulating ASDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndomethacinExcipientsPolymersSolubilityHot Melt Extrusion TechnologyCrystallizationDrug CompoundingPovidonePyrrolidinesVinyl Compounds

Stichwörter der Autor:innen

Amphiphilic block copolymerDrug formulationPoly(2-oxazine)Poly(2-oxazoline)Poly(vinyl pyrrolidone)Poly(vinyl pyrrolidone-co-vinyl acetate)

Substanzen

IndomethacinExcipientsPolymerspoly(vinylpyrrolidone-co-vinyl-acetate)PovidonePyrrolidinesVinyl Compounds

Autor:innen und Institutionen

  • Soft Matter Chemistry, Department of Chemistry, and Helsinki Institute of Sustainability Science, Faculty of Science, University of Helsinki, Helsinki 00014, Finland.
  • Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki 00790, Finland.
  • Department of Chemistry, University of Helsinki, P.O. Box 55, Helsinki FIN-00014, Finland.
  • Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki 00790, Finland; Laboratory of Pharmaceutical Technology, Ghent University, Ghent 9000, Belgium.
  • Department of Pharmacy, University of Copenhagen, Copenhagen 2100, Denmark.
  • Pharmaceutical Sciences, Orion Corporation, Espoo 02200, Finland.

Förderung

  • Research Council of Finland

Zitieren

APA

Keßler, L., Mishra, R., Hietala, S., Lammens, M., Peltonen, L., Rades, T., van Veen, B., Juppo, A., Laaksonen, T., Strachan, C., & Luxenhofer, R. (2025). Amorphous solid dispersions of amphiphilic polymer excipients and indomethacin prepared by hot melt extrusion. European Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.ejps.2024.106960

Vancouver

Keßler L, Mishra R, Hietala S, Lammens M, Peltonen L, Rades T, et al. Amorphous solid dispersions of amphiphilic polymer excipients and indomethacin prepared by hot melt extrusion. European Journal of Pharmaceutical Sciences. 2025. doi:10.1016/j.ejps.2024.106960

BibTeX
@article{Keler2025,
  author = {Keßler, Larissa and Mishra, Rashmi and Hietala, Sami and Lammens, Manon and Peltonen, Leena and Rades, Thomas and van Veen, Bert and Juppo, Anne and Laaksonen, Timo and Strachan, Clare and Luxenhofer, Robert},
  title = {Amorphous solid dispersions of amphiphilic polymer excipients and indomethacin prepared by hot melt extrusion},
  journal = {European Journal of Pharmaceutical Sciences},
  year = {2025},
  doi = {10.1016/j.ejps.2024.106960}
}
Kostenlos starten →